Showing results (641-650 of 10,067) with videos related to
Sort By:
Pageof 1,007
Current Pharmaceutical Design|March 12, 2009
Vanilloid receptor antagonists: emerging class of novel anti-inflammatory agents for pain managementManojit Pal, Sowjanya Angaru, Arumugam Kodimuthali, et al.Current Pharmaceutical Design|June 13, 2009
Pharmaceutical and cellular strategies in prophylaxis and treatment of graft-versus-host diseaseD Wolff, B Steiner, G Hildebrandt, et al.Current Pharmaceutical Design|June 13, 2009
Overview of the role of macrophage migration inhibitory factor (MIF) in inflammatory bowel diseaseJun Nishihira, Keiichi MitsuyamaCurrent Pharmaceutical Design|June 13, 2009
Recent advances in molecular approaches to gut microbiota in inflammatory bowel diseaseAkira Andoh, Yoshimi Benno, Osamu Kanauchi, et al.Current Pharmaceutical Design|June 13, 2009
HCN pacemaker channels and pain: a drug discovery perspectiveA D Wickenden, M P Maher, S R ChaplanCurrent Pharmaceutical Design|December 17, 2008
Pathogenesis of and therapeutic strategies to ameliorate the transthyretin amyloidosesYoshiki Sekijima, Jeffery W Kelly, Shu-ichi IkedaCurrent Pharmaceutical Design|December 17, 2008
Alpha-synuclein assembly as a therapeutic target of Parkinson's disease and related disordersKenjiro Ono, Mie Hirohata, Masahito YamadaCurrent Pharmaceutical Design|December 17, 2008
Proliferation markers for the differential diagnosis of tumor and inflammationAren van Waarde, Philip H ElsingaCurrent Pharmaceutical Design|December 17, 2008
Growth factor/peptide receptor imaging for the development of targeted therapy in oncologyChristophe Van de Wiele, Hendricus Boersma, Rudi A Dierckx, et al.Current Pharmaceutical Design|December 17, 2008
Development of radioligands for in vivo imaging of type 1 cannabinoid receptors (CB1) in human brainAndrew G Horti, Koen Van LaerePageof 1,007